A counterintuitive philosophy is gaining traction among healthcare strategists: building specialty drug networks that begin with a narrow, focused footprint rather than broad reach. That argument was put forward by three industry
Weil insiders have made little effort to conceal their indifference toward the departure of Mike Aiello, one of the firm’s most prominent partners. The reaction from within the firm has been notable
More
The FTSE 100 rose at the start of a pivotal week for global monetary policy, with defensive stocks leading gains across the index. Investors rotated into traditionally safer sectors as markets braced
More
Novo Nordisk is streamlining its public identity, adopting “Novo” as its everyday brand name while retaining Novo Nordisk A/S as its legal global company name. The move places the Danish pharmaceutical giant
More
A significant challenge to federal patent policy has failed without a court ever ruling on whether the disputed practice was actually lawful. The Federal Circuit’s decision in US Inventor, Inc. v. Squires,
More
The Department of Justice has entered a Florida courtroom to defend both government lawyers and Donald Trump’s personal attorneys against potential sanctions. The intervention comes eight months after Trump filed a lawsuit
More
SFL Corporation (SFL) has secured a seven-year charter extension, a move that analysts suggest keeps the company’s valuation broadly in line with its intrinsic worth. Charter extensions of this length are considered
More
Cautious sentiment is building around one particular FTSE 250 stock, with analysts and private investors urging patience before taking any position. The FTSE 250 index is home to a broad range of
More
The U.S. biopharmaceutical market is no longer operating under a single dominant economic model, according to industry analyst Bill Roth. Writing in the final instalment of his Great Repricing series, Roth argues
More
Fast-fashion giant Shein is facing significant hurdles in its pursuit of a Hong Kong stock exchange listing, with profitability concerns casting a long shadow over its ambitions. The company, which built its
More
London’s benchmark index edged higher on Monday as rising oil prices driven by Middle East supply disruptions lifted sentiment across UK markets. The FTSE 100 gained 0.53% as of 03:15 ET, while
More